Development of Pharmaceutical Dosage Form with New Sibutramine Salt
![]() |
Moon, Jin-Wook
(College of Pharmacy, Chungnam National University)
Shin, Teak-Hwan (Chong Kun Dang Pharmaceutical Co.) Lee, Dong-Wook (Chong Kun Dang Pharmaceutical Co.) Cho, Jun-Young (Chong Kun Dang Pharmaceutical Co.) Chang, Sung-Ju (Chong Kun Dang Pharmaceutical Co.) Hwang, Sung-Joo (College of Pharmacy, Chungnam National University) |
1 | 한올제약, 용해도와 용출률이 향상된 시부트라민 함유 경구투여용 고체분산체, 대한민국특허청, 10-2006-0061063 |
2 |
S.C. Cheetham, J.A. Viggers, S.A. Butler, M.R. Prow and D.J. Heal, [ |
3 | I.P. Connoley, Y.L. Liu, I. Frost, I.P. Reckless, D.J. Heal and M.J. Stock, Thermogenic effects of sibutramine and its metabolites. Brit. J. Pharmacol., 126, 1487-1495 (1999). DOI |
4 | I.P. Connoley, I. Frost, D.J. Heal and M.J. Stock, Role of beta-adrenoceptors in mediating the thermogenic effects of sibutramine, Brit. J. Pharmacol., 117, 170 (1996). DOI ScienceOn |
5 | Z. Abolfathi, J. Couture, F. Vallee, M. LeBel, M. Tanguay and E. Masson, A pilot study to evaluate the pharmacokinetics of sibutramine in healthy subjects under fasting and fed conditions. J. Pharm. Pharmaceut. Sci., 7(3), 345-349 (2004). |
6 | 더 부츠 캄파니 피엘씨, 1-(1-아릴사이클로부틸)알킬아민 유도체의 제조방법, 대한민국특허청, 10-1982-0001506 |
7 | 더 부츠 캄파니 피엘씨, N,N-디메틸-1-(1-(4-클로로페닐)사이클로부틸)-3-메틸부틸아민 염산염 일수화물의 제조방법, 대한민국특허청, 10-1986-0010764 |
8 | H.C. Jackson, A.M. Needham, L.J. Hutchins, S.E. Mazurkiewicz and D.J. Heal, Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat, Br. J. Pharmacol., 121, 1758–1762 (1997b). DOI |
9 | H.C. Jackson, M.C. Bearham, L.J. Hutchins, S.E. Mazurkiewicz, A.M. Needham and D.J. Heal, Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat, Br. J. Pharmacol., 121, 1613-1618 (1997a). DOI |
10 |
S.C. Cheetham, C.J. Kettle, K.F. Martin and D.J. Heal, |
11 | M.J. Stock, Sibutramine: a review of the pharmacology of a novel anti obesity agent, Int. J. Obes., 21 (Suppl. 1), S25-S29 (1997). |
12 | 유한양행, 시부트라민을 함유하는 약제학적 조성물, 대한민국 특허청, 10-2005-0080825 |
13 | 한미약품, 시부트라민 메탄술폰산염의 결정성 반수화물을 포함하는 약학조성물, 대한민국특허청, 10-2003-0053752 |
14 | W.R. Buckett, P.C. Thomas and G.P. Luscombe, The pharmacology of sibutramine hydrochloride (BTS 54 524) a new antidepressant which induces rapid noradrenergic downregulation, Prog. Neuropsychopharmacol. Biol. Psychiatry.,12(5), 575-584 (1988). DOI |
15 | M. Weintraub, A. Rubio, A. Golik, L. Byrne and M.L. Scheinbaum, Sibutramine in weight control: a dose-ranging efficacy study, Clin. Pharmacol. Ther., 50(3), 330-337 (1991). DOI |
16 | G.P. Luscombe, N.A. Slater, M.B. Lyons, R.D. Wynne, M.L. Scheinbaum and W.R. Buckett, Effect on radiolabeledmonoamine uptake in vitro of plasma taken from healthyvolunteers administered the antidepressant sibutramine HCl,Psychopharmacology, 100, 345-349 (1990). DOI |
17 |
S.C. Cheetham, J.A. Viggers, N.A. Slater, D.J. Heal and W.R. Buckett, [ |
18 | B.J. Rolls, C.J. Shide, M.L. Thorwart and J.S. Ulbrecht, Sibutramine reduces food intake in nondieting women with obesity. Obes. Res., 6, 1-11 (1998). DOI ScienceOn |
19 | D.L. Hansen, S. Toubro, M.J. Stock, I.A. Macdonald and A. Astrup, Thermogenic effects of sibutramine in humans, Am. J. Clin. Natr., 68, 1180-1186 (1998). DOI |
![]() |